INR 1079.4
(-1.12%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 58.97 Billion INR | 59.19% |
2022 | 37.04 Billion INR | -19.08% |
2021 | 45.78 Billion INR | -5.49% |
2020 | 48.43 Billion INR | -31.38% |
2019 | 70.58 Billion INR | 2.25% |
2018 | 69.03 Billion INR | -10.41% |
2017 | 77.05 Billion INR | -0.38% |
2016 | 77.34 Billion INR | 41.23% |
2015 | 54.76 Billion INR | 1.11% |
2014 | 54.16 Billion INR | 25.26% |
2013 | 43.24 Billion INR | 3.49% |
2012 | 41.78 Billion INR | 34.06% |
2011 | 31.16 Billion INR | 12.44% |
2010 | 27.72 Billion INR | 364.89% |
2009 | 5.96 Billion INR | -2.88% |
2008 | 6.13 Billion INR | 17.95% |
2007 | 5.2 Billion INR | 17.06% |
2006 | 4.44 Billion INR | 67.65% |
2005 | 2.65 Billion INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 68.13 Billion INR | 0.0% |
2023 Q4 | 58.97 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 61.19 Billion INR | 0.0% |
2023 FY | 58.97 Billion INR | 59.19% |
2022 Q2 | 38.48 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 FY | 37.04 Billion INR | -19.08% |
2022 Q4 | 37.04 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 Q2 | 47.58 Billion INR | 0.0% |
2021 FY | 45.78 Billion INR | -5.49% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 45.78 Billion INR | 0.0% |
2020 Q4 | 48.43 Billion INR | 0.0% |
2020 FY | 48.43 Billion INR | -31.38% |
2020 Q2 | 54.83 Billion INR | 0.0% |
2019 Q2 | 68.7 Billion INR | 0.0% |
2019 Q4 | 70.58 Billion INR | 0.0% |
2019 FY | 70.58 Billion INR | 2.25% |
2018 Q4 | 69.03 Billion INR | 0.0% |
2018 FY | 69.03 Billion INR | -10.41% |
2018 Q2 | 76.34 Billion INR | 0.0% |
2017 Q4 | 77.05 Billion INR | 0.0% |
2017 Q2 | 73.91 Billion INR | 0.0% |
2017 FY | 77.05 Billion INR | -0.38% |
2016 Q2 | 79.71 Billion INR | 0.0% |
2016 Q4 | 77.34 Billion INR | 0.0% |
2016 FY | 77.34 Billion INR | 41.23% |
2015 Q2 | 49.79 Billion INR | 0.0% |
2015 FY | 54.76 Billion INR | 1.11% |
2015 Q4 | 54.76 Billion INR | 0.0% |
2014 Q2 | 41.53 Billion INR | 0.0% |
2014 Q4 | 54.16 Billion INR | 0.0% |
2014 FY | 54.16 Billion INR | 25.26% |
2013 Q2 | 44.4 Billion INR | 0.0% |
2013 Q4 | 43.24 Billion INR | 0.0% |
2013 FY | 43.24 Billion INR | 3.49% |
2012 Q4 | 41.78 Billion INR | 0.0% |
2012 FY | 41.78 Billion INR | 34.06% |
2011 Q4 | 31.16 Billion INR | 0.0% |
2011 FY | 31.16 Billion INR | 12.44% |
2010 FY | 27.72 Billion INR | 364.89% |
2009 FY | 5.96 Billion INR | -2.88% |
2008 FY | 6.13 Billion INR | 17.95% |
2007 FY | 5.2 Billion INR | 17.06% |
2006 FY | 4.44 Billion INR | 67.65% |
2005 FY | 2.65 Billion INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ador Multiproducts Limited | 28.52 Million INR | -206620.415% |
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -5262.165% |
Bajaj Consumer Care Limited | 1.53 Billion INR | -3754.43% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | -346.033% |
Cupid Limited | 186.52 Million INR | -31516.611% |
Dabur India Limited | 48.19 Billion INR | -22.361% |
Emami Limited | 8.21 Billion INR | -617.444% |
Gillette India Limited | 8.59 Billion INR | -586.15% |
Hindustan Unilever Limited | 270.76 Billion INR | 78.219% |
Hipolin Limited | 48.57 Million INR | -121311.484% |
Honasa Consumer Limited | 5.36 Billion INR | -998.662% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | -21604.784% |
Jyothy Labs Limited | 5.9 Billion INR | -898.327% |
Kaya Limited | 5.22 Billion INR | -1029.239% |
Marico Limited | 32.52 Billion INR | -81.344% |
N.K Industries Limited | 22.4 Billion INR | -163.239% |
PAOS INDUSTRIES LIMITED | 163.96 Million INR | -35866.067% |
Paramount Cosmetics (India) Limited | 205.72 Million INR | -28566.035% |
Pee Cee Cosma Sope Limited | 80.17 Million INR | -73451.928% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | -444.184% |